期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌靶向治疗的研究进展及未来方向 被引量：2

原文传递
导出
摘要 Her2被证实是一个有效的分子靶向治疗的靶标,笔者就目前以Her2为靶点的抗肿瘤研究进展进行综述,主要包括该基因的生物学功能及其与乳腺癌的发生、发展和侵袭转移的关系,并探讨乳腺癌治疗新策略。
作者 朱克鹏 杨光伦
机构地区 重庆医科大学附属第一医院普通外科
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2011年第5期541-545,共5页 China Journal of General Surgery
关键词 乳腺肿瘤/药物疗法 Her2 抗-Her2药物 曲妥珠单抗 拉帕替尼
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献40

  • 1Baselga J. Treatment of Her2-overexpressing breast cancer [ J ]. Ann Oncd, 2010, 21 (Suppl 7):vii36-vii40.
  • 2Alvarez RH. Present and future evolution of advanced breast cancer therapy[J]. Breast Cancer Res, 2010, 12 (Suppl 2) :S1.
  • 3Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogenc [ J ]. Science, 1987, 235 (4785) :177 - 182.
  • 4Surer R, Marcum JA. The molecular genetics of breast cancer and targeted therapy[J]. Biologics, 2007, 1 (3) :241 - 258.
  • 5Stankovic S, Konjevic G, Gopcevic K, et al. Activity of MMP-2 and MMP-9 in sera of breast cancer patients [ J ]. Pathol Res Pract, 2010, 206 (4) :241 - 247.
  • 6Muraki C, Ohga N , Hida Y, et al. Cyclooxygenasc-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells[J], lnt J Cancer, 2011 , doi: 10. 1002/ijc. 25976.
  • 7Wang KH, Kao AP, Chang CC, et al. Increasing CD44 +/ CD24(-) tumor stem cells, and upregulation of COX-2 and HDAC6 , as major functions of Her2 in breast tumorigenesis[J]. Mol Cancer, 2010, 9:288.
  • 8Liu M, Ju X, Wilimarth NE, et al. Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo [ J ]. Am J Pathol, 2009, 174(5) : 1910-1920.
  • 9Gross JC, Schreiner A, Engels K, et al. E-cadherin surface levels in epithelial growth factor-stimulated cells depend on adherens junction protein shrew-1 [ J ]. Mol Biol Cell, 2009, 20(15) :3598 -3607.
  • 10张超杰,唐利立,欧阳慧英,任力锋,邬玉辉,罗庚求.Pirh2 mRNA,Her-2,VEGF,MVD及TNF-α对Ⅰ,Ⅱ期乳腺癌预后的影响[J].中国普通外科杂志,2009,18(5):447-453. 被引量：5

二级参考文献15

  • 1欧周罗,王杰,侯意枫,罗建民,沈镇宙,邵志敏.Duffy抗原趋化因子受体参与人乳腺癌的淋巴结转移[J].中华肿瘤杂志,2006,28(8):586-589. 被引量：5
  • 2苏远,白明,朱莉萍,金阳,张晓菊,周琼.泛素连接酶pirh2短发夹状RNA对肺癌细胞生长抑制的实验研究[J].中华医学杂志,2007,87(17):1199-1203. 被引量：4
  • 3孟洁,郎荣刚,范宇,付丽.年轻乳腺癌患者的病理学和生物学特征及其与预后的关系[J].中华肿瘤杂志,2007,29(4):284-288. 被引量：29
  • 4Peley G, Toth J, Csuka, et al. Immunohistoehemistry and reverse transcriptase polymerase chain reaction on sentinel lymph nodes can improve the accuracy of nodal staging in breast cancer patients[J].Int J Biol Markers, 2001, 16 (4) : 227 -232.
  • 5Hamid R, Mirshahidi HR, Abraham J. Jame Abraham. Managing early breast cancer:Prognostic features guide choice of therapy[J]. Postgrad Med,2004, 116(4) :23 -26;32 -34.
  • 6Goncalves A, Esterni B, Bertucci F, et al. Postoperative serum proteomic profiles may predict metastatic relapse in high- riskprimary breast cancer patients receiving adjuvant chemotherapy[J]. Oncogene,2006,25(3) : 981 -989.
  • 7Weidner N, Semple JP, Welch ER, et al. Tumor anjiogenesis and metastasis- correlation in invasive breast carcinoma [ J ]. N engl J Med,1991,324(1) :1 -2.
  • 8Evangelos T, Andreas K, Christos D, et al. HER2/neu Expression and gene alterations in pancreatic ductal adenocarcinoma: A comparative Immunohis-tochemistry and chromogenic in situ hybridization study based on tissue mieroarrays and computerized image analysis [ J ]. J Pancreas ( Online ) , 2006, 7(3) :283-294.
  • 9Beitel LK, Elhaji YA, Lumbroso R, et al. Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin - protein ligase activity [ J ]. J Mol Endocrinol,2002, 29 (1) :41 - 60.
  • 10Leng RP, Lin Y, Ma W, et al. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation [ J ]. Cell. 2003,112(6) :779 -791.

共引文献4

同被引文献51

  • 1刘俊田,岳杰,任秀宝,李慧.乳腺癌患者外周血CD_4^+CD_(25)^+调节性T细胞的检测及意义[J].中华肿瘤杂志,2005,27(7):423-425. 被引量：30
  • 2岑东芝,李扬秋,陈少华,杨力建,郁志.APL患者外周血TCR Vα亚家族T细胞分布和增殖特点[J].临床肿瘤学杂志,2007,12(2):81-84. 被引量：7
  • 3Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T ceils expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol, 1995, 155(3):1151- 1164.
  • 4Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-sell[J].Nat Immunol, 2005, 6(4):345-352.
  • 5Hori S, Nomra T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [J]. Science, 2003, 299(5609):1057-1061.
  • 6Ziegler SF. FOXP3: not just for regulatory T cells anymore[J]. Eur J Immunol, 2007, 37(1):21-23.
  • 7Morgan ME, van Bilsen JH, Bakker AM, et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans[J]. Hum Immunol, 2005, 66(1):13-20.
  • 8Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells[J]. J Exp Med, 2006, 203(7):1693- 1700.
  • 9Hartigan-O'Connor DJ, Poon C, Sinclair E, et al. Human CD4+ regulatory T eeUs express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells[J]. J Immunol Methods, 2007, 319(1/2):41-52.
  • 10Abo-Elenein A, Elgohary SE, Hashish A, et al. Significance of immunoregulatory T cells in different stages of breast cancer patients[J]. Egypt J Immunol, 2008, 15(2):145-152.

引证文献2

中国普通外科杂志
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部